Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
NeurAegis, Inc. Logo
NeurAegis, Inc. Growth Score
61
CB Rank
116413
Heat Score
41
NeurAegis is a privately held pharmaceutical company pioneering the development of breakthrough treatments for neurological disorders.
Founded
obfuscation
PrivateGrant Irvine, California, United States1-10 www.neuraegis.com
Biotechnology
Health Care
Neuroscience
Pharmaceutical
Overview

NeurAegis, Inc.
Total Funding
obfuscation
Growth Score
61
Heat Score
41

Total Funding
obfuscation
obfuscation
Grant raised
obfuscation
Growth Score61
-4 pts
in past quarter
Heat Score 41
-13 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About NeurAegis, Inc.

CB Rank
116413
NeurAegis is a privately held pharmaceutical company pioneering the development of breakthrough treatments for neurological disorders.
Founded
obfuscation
PrivateGrant Irvine, California, United States1-10 www.neuraegis.com
Biotechnology
Health Care
Neuroscience
Pharmaceutical

Funding Rounds

Grant
OBF
in
obfuscation

Key People

Details

Legal Name NeurAegis, Inc.
Operating Status Active
Company Type For Profit
Founders  Joseph Blanchard, MBA, Michel Baudry, PhD, Michel Baudry, PhD
About the Company
NeurAegis is a preclinical stage neuropharmaceutical company pioneering the development of breakthrough treatments for neurological disorders. Founded in 2016, our initial focus is developing first-in-class, novel protease inhibitors for mild traumatic brain injury (concussion) where there are currently no FDA approved treatments.
Contact Email info@neuraegis.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

NA184
NA184 is a selective inhibitor of calpain-2 protease designed to reduce neurodegeneration following traumatic brain injury (TBI).
Novel Protease Inhibitors for Neurological Disorders
NeurAegis develops novel protease inhibitors targeting neurological disorders such as TBI and epilepsy to address neuronal damage and degeneration.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - NeurAegis, Inc. Logo
Grant - NeurAegis, Inc.
1
obfuscation
Combat Casualty Care Research ProgramGrant
obfuscation
Grant - NeurAegis, Inc. Logo
Grant - NeurAegis, Inc.
1
obfuscation
Combat Casualty Care Research ProgramGrant
obfuscation
Grant - NeurAegis, Inc. Logo
Grant - NeurAegis, Inc.
1
obfuscation
Combat Casualty Care Research ProgramGrant
obfuscation
Grant - NeurAegis, Inc. Logo
Grant - NeurAegis, Inc.
1
obfuscation
Combat Casualty Care Research ProgramGrant
obfuscation
Grant - NeurAegis, Inc. Logo
Grant - NeurAegis, Inc.
1
obfuscation
Combat Casualty Care Research ProgramGrant

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - NeurAegis, Inc. Logo
Grant - NeurAegis, Inc.
1
obfuscation
Combat Casualty Care Research ProgramGrant
obfuscation
Grant - NeurAegis, Inc. Logo
Grant - NeurAegis, Inc.
1
obfuscation
Combat Casualty Care Research ProgramGrant
obfuscation
Grant - NeurAegis, Inc. Logo
Grant - NeurAegis, Inc.
1
obfuscation
Combat Casualty Care Research ProgramGrant
obfuscation
Grant - NeurAegis, Inc. Logo
Grant - NeurAegis, Inc.
1
obfuscation
Combat Casualty Care Research ProgramGrant
obfuscation
Grant - NeurAegis, Inc. Logo
Grant - NeurAegis, Inc.
1
obfuscation
Combat Casualty Care Research ProgramGrant

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 2 Board Members and Advisors 5 Contacts 1

Employee Profiles

Board Members and Advisors

News

News and Press

News•Dec 10, 2020
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jul 1, 2020
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

IT Spend

$88.2KThis year, NeurAegis, Inc. is projected to spend $88.2K on IT, according to Aberdeen.

Active Website Tech Count

21NeurAegis, Inc. is actively using 21 technologies for its website, according to BuiltWith. These include Viewport Meta, IPhone / Mobile Compatible, and  SSL by Default.
Sub-Organizations
Frequently Asked Questions

Where is NeurAegis, Inc.'s headquarters? NeurAegis, Inc. is located in Irvine, California, United States.Who invested in NeurAegis, Inc.? NeurAegis, Inc. is funded by Combat Casualty Care Research Program.When was the last funding round for NeurAegis, Inc.? NeurAegis, Inc. closed its last funding round on
obfuscation
from a Grant round.Who are NeurAegis, Inc.'s competitors? Alternatives and possible competitors to NeurAegis, Inc. may include Amylyx Pharmaceuticals, Neurelis, and  Praxis Precision Medicines.How much funding has NeurAegis, Inc. raised to date? NeurAegis, Inc. has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(ccb7a32 1)
|